You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Yttrium-Ibritumomab

Showing 1 - 25 of 217
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)

Active, not recruiting
  • Graft Versus Host Disease
  • +2 more
  • rituximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Lymphoma Trial in United Kingdom (biological, drug, radiation)

Terminated
  • Lymphoma
  • rituximab
  • +5 more
  • Manchester, England, United Kingdom
  • +4 more
Dec 16, 2021

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting
  • Ann Arbor Stage I Grade 1 Follicular Lymphoma
  • +9 more
  • Quality-of-Life Assessment
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 3, 2022

Lymphoma Trial (biological, drug, procedure, radiation)

Completed
Has Results
  • Lymphoma
  • filgrastim
  • +4 more
  • (no location specified)
Jun 16, 2021

Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)

Completed
Has Results
  • Lymphoma, Follicular
  • Scarborough, Maine
  • +3 more
Apr 27, 2021

Lymphoma Trial in New York, Houston (biological, drug, radiation)

Completed
Has Results
  • Lymphoma
  • darbepoetin alfa
  • +8 more
  • New York, New York
  • +1 more
Oct 19, 2020

Lymphoma Trial in United States (biological, drug, radiation)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +7 more
  • Anchorage, Alaska
  • +47 more
Dec 22, 2021

Primary CNS Non-Hodgkin Lymphoma Trial in Cleveland (rituximab, yttrium Y 90 ibritumomab tiuxetan)

Terminated
Has Results
  • Primary Central Nervous System Non-Hodgkin Lymphoma
  • rituximab
  • yttrium Y 90 ibritumomab tiuxetan
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 23, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (ibritumomab tiuxetan, BEAM chemo and autologous stem-cell transplantation)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • ibritumomab tiuxetan
  • BEAM chemotherapy and autologous stem-cell transplantation
  • Scottsdale, Arizona
  • +8 more
Aug 13, 2020

Relapsed Follicular Lymphoma Trial in Italy (ZEVALIN, BEAM)

Active, not recruiting
  • Relapsed Follicular Lymphoma
  • Genova, GE, Italy
  • +37 more
Dec 22, 2022

Leukemia, Lymphoma Trial in Houston (Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Lymphoma Trial in Tucson (Methylprednisolone, Etoposide, Cytarabine)

Completed
Has Results
  • Lymphoma
  • Tucson, Arizona
    The University of Arizona Cancer Center
Aug 23, 2019

Non-Hodgkin's Lymphoma (NHL) Trial in Chicago (Rituxan, motexafin gadolinium, 111Indium-Zevalin and 90Yttrium-Zevalin)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma (NHL)
  • Chicago, Illinois
  • +1 more
Jul 12, 2019

Lymphoma Trial in Switzerland (ibritumomab tiuxetan, rituximab, melphalan)

Completed
  • Lymphoma
  • ibritumomab tiuxetan
  • +4 more
  • Aarau, Switzerland
  • +9 more
May 13, 2019

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Yttrium-90 carbon microspheres SIRT
  • Nanjing, China
    Gao-Jun Teng
Jul 20, 2023

Follicular Lymphoma Trial in United States (Zevalin, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Sun City, Arizona
  • +4 more
Sep 6, 2021

Urethral Stricture, Male Trial in Cairo (Ho-YAG Laser Visual internal urethrotomy, Ho-YAG Laser Visual internal urethrotomy

Completed
  • Urethral Stricture, Male
  • Ho-YAG Laser Visual internal urethrotomy
  • Ho-YAG Laser Visual internal urethrotomy combined with intralesional submucosal injection of Paclitaxel
  • Cairo, Egypt
    Demerdash hospital, Faculty of medicine, Ain Shams University
Nov 7, 2023

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Completed
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Yttrium Y 90 Glass Microspheres
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

Active, not recruiting
  • Metastatic Liver Carcinoma
  • +3 more
  • Angiography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon

Recruiting
  • Unresectable Colorectal Liver Metastases
  • Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jan 26, 2023

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Active, not recruiting
  • Advanced Adult Primary Liver Cancer
  • +3 more
  • positron emission tomography
  • computed tomography
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022

Thrombocytopenia, Cirrhosis Trial in Chicago (TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.)

Recruiting
  • Thrombocytopenia
  • Cirrhosis
  • TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
  • Chicago, Illinois
    Northwestern University/Northwestern Memorial Hospital
Sep 7, 2022